Medicine News and Research

RSS

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.

15 Nov 2005

Study suggests that some patients on beta blockers should not be

A Johns Hopkins study has raised doubts about a long-accepted notion of what's going on in many cases of heart failure, suggesting that nearly half of patients with the disorder may be getting the wrong treatment for their disease.

15 Nov 2005

Tricor disappoints in diabetes trial

Researchers say the results of a large trial of a drug to lower triglycerides failed in its primary goal of significantly reducing heart attacks and coronary deaths among patients with type II diabetes.

15 Nov 2005

It's true! study confirms that Glucosamine and Chondroitin relieve arthritis pain

The millions of Osteoarthritis sufferers in the world will welcome the good news that a new study has confirmed that the dietary supplements glucosamine and chondroitin provide pain relief.

15 Nov 2005

Good fitness levels may extend the lives of women with metabolic syndrome

A high level of fitness may extend the lives of women with metabolic syndrome, according to new findings presented today by a cardiologist at Northwestern Memorial Hospital at the annual American Heart Association Scientific Sessions.

15 Nov 2005

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Results from a new study show that amlodipine-based (calcium channel blocker) treatment is much more effective at reducing blood pressure near the heart than a conventional atenolol-based (beta blocker) regimen.

14 Nov 2005

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

Teenage suicides and Tamiflu - is there a link?

Roche the maker of the anti-flu drug Tamiflu has reported to authorities in Japan the possible suicides of two teenage boys although the company says there was no clear evidence that the drug had contributed to their deaths.

14 Nov 2005

Norvasc better than beta blockers for lowering blood pressure

According to a study presented at a meeting of the American Heart Association, Norvasc, was more effective at reducing blood pressure near the heart than standard, older treatments such as beta blockers.

14 Nov 2005

$230 billion in health care spending nationally is devoted to insurance administration

Billing and insurance paperwork consume at least one out of every five dollars of private insurance health spending in California, according to a new study by health policy researchers.

14 Nov 2005

Nerve-cell dendrites splice messenger RNA

Researchers at the University of Pennsylvania School of Medicine have discovered that nerve-cell dendrites have the capacity to splice messenger RNA (pre-mRNA), a process once believed to only take place in the nucleus of cells.

14 Nov 2005

New respiratory synctial virus treatment for at-risk infants under study

A new, enhanced-potency onoclonal antibody designed to keep the sniffles from turning into a devasting illness in at-risk babies is under study at the Medical College of Georgia Children's Medical Center.

14 Nov 2005

Bright light therapy may aid patients with depressive and bipolar disorders

A report in the November Cell Metabolism reveals powerful effects of light on the adrenal glands, a finding that might explain the broad benefits of bright light therapy for a variety of conditions, including sleep and depressive disorders, according to researchers.

14 Nov 2005

Role of statin therapy in patients with heart failure

An advanced study launched at Yale School of Medicine is evaluating the role of statin therapy in patients with heart failure, one of the leading causes of hospitalization in people over age 65.

14 Nov 2005

Positive aspects of bipolar disorder

Researchers at the Stanford University School of Medicine have shown for the first time that a sample of children who either have or are at high risk for bipolar disorder score higher on a creativity index than healthy children.

14 Nov 2005

Gender affects the way a person's brain responds to humor

Need more evidence that men and women are different? Look no further than the Sunday funnies. According to a new Stanford University School of Medicine study, gender affects the way a person's brain responds to humor.

14 Nov 2005

Prevalence of major psychiatric disorders is as common in cancer patients

The prevalence of major psychiatric disorders is as common in cancer patients as they are in the general population, with the exception of panic disorder which had elevated rates compared to the general population (5 percent versus 1.7 percent, respectively).

14 Nov 2005

Women should continue to exercise during pregnancy

Obstetricians and gynecologists need to do a better job of encouraging women with uncomplicated pregnancies to exercise, a Saint Louis University School of Public Health study concludes.

14 Nov 2005

Findings imply that cognitive difficulties can be detected early

The rate of premature births in the United States is on the rise, with one in eight babies born before 37 weeks gestation in 2003, a 13 percent increase from 10 years ago.

14 Nov 2005

Fundamental flaws in many medical studies must be fixed in order to catch signs of harm

Only by analyzing results using a statistical method that considers several factors at once -- for instance, overall heart attack risk, rather than just individual risk factors such as age -- will researchers truly be able to see how the risks and benefits of a treatment vary from patient to patient, the study suggests.

14 Nov 2005